1. P1602: THE ASSESSMENT OF LYMPHOPENIA AS RISK FACTOR FOR UNFAVORABLE EVOLUTION OF PATIENTS WITH SEVERE FORM OF COVID 19. (23rd June 2022) Authors: Popov, V.; Iliescu, L.; Grigorie, A.; Pirvu, C.; Constantin, O.; Badea, A.; Badoiu Niculae, M. D.; Rus, A.; Calen, A.; Bumbea, H.; Mastalier, B.; Andreescu, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. (23rd June 2022) Authors: Jang, J. H.; Demichelis Gomez, R.; Bumbea, H.; Nogaieva, L.; Wong, L. L. L.; Lim, S. M.; Park, J.; Kim, Y.; Cho, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PB2259: MONOCYTE'S INVOLVEMENT IN INFLAMMATORY RESPONSE IN COVID-19 INFECTION IN CHRONIC RENAL DISEASE. (23rd June 2022) Authors: Bumbea, V.; Bumbea, H.; Ardelean, L.; Radulescu, L.; Damian, L.; Dumitru, I.; Lambert, C.; Popov, V.; Tomuleasa, C.; Vladareanu, A.-M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗